Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects

NCT00544921 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: GLY-230
OTHER: Placebo

Sponsor

Glycadia

Collaborators

[object Object]